Pay in 4 interest-free payments of $116.25 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Branched Linkers for Homogeneous Antibody-Drug Conjugates: How Long Is Long Enough
1039/C9CC08744C
Platform for Orthogonal N-Cysteine-Specific Protein Modification Enabled by Cyclopropenone Reagents
Fab-PEG-Fab as a Potential Antibody Mimetic
Trifunctional Dibromomaleimide Reagents Built Around A Lysine Scaffold Deliver Site-selective Dual-modality Antibody Conjugation
Dibromopyridazinediones-N-ethyl-N'-Propanamido-PEG3-C3-TCO Quantity:500 mg Branched Linkers for Homogeneous Antibody-DrugReferences: Schauenburg, D.; et al. Macrocyclic Dual Locked Turn On Drug for Selective and Traceless Release in Cancer Cells Angew. Chem. Int. Ed. (2024), 63, e202314143 DOI: 10. 1002 anie. 202314143 Keywords: Traceless Release; Bis sulfone; DBCO
US$ 199.26
US$ 109.00
US$ 107.00